Open House Drug Rebate Agreements Denosumab Atc M05Bx04

Deadline: 05 Sep 2026

Germany

Ref. No.: 8804091

EMD:Ref Document

Bid Value: Ref Document

8 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Bosutinib L01Ea04 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8803968

EMD:Ref Document

Bid Value: Ref Document

3 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Timolol Brinzolamide Atc S01Ed67 Obg For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8801281

EMD:Ref Document

Bid Value: Ref Document

8 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Allergen Extract Of Various Origins Subcutaneous Syringes V01Aa02 V01Aa03 V01Aa05 For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8800167

EMD:Ref Document

Bid Value: Ref Document

8 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Interferon Beta 1A Exclusively For Subcutaneous Use Atc L03Ab07 For The Period 01 11 2024 31 10 2026

Deadline: 05 Sep 2026

Germany

Ref. No.: 8798282

EMD:Ref Document

Bid Value: Ref Document

8 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgotinib L04Af04 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8796348

EMD:Ref Document

Bid Value: Ref Document

3 Days Left

907 O070 23 2285 Accommodation Of The Service And Crew Vessel Zvezda For The Period Of Winter Lay Up 2024 2025 2025 2026 2026 2027

Deadline: 14 May 2027

Russia

Ref. No.: 8795090

EMD:Ref Document

Bid Value: Ref Document

259 Days Left

Open House Drug Rebate Agreements Sorafenib Atc L01Ex02

Deadline: 05 Sep 2026

Germany

Ref. No.: 8793928

EMD:Ref Document

Bid Value: Ref Document

8 Days Left

Open House Drug Discount Agreements Naproxen Atc M01Ae02

Deadline: 05 Sep 2026

Germany

Ref. No.: 8793766

EMD:Ref Document

Bid Value: Ref Document

8 Days Left

General Rfp 3850 To Enhance The Existing Vendor Pool To Be Used In The Managed Service Provider Process For The Acquisition Of Information Systems Consulting Services For The State Of Mississippi Proposals Accepted Until September 30 2026

Deadline: 30 Sep 2026

United States

Ref. No.: 8793220

EMD:Ref Document

Bid Value: Ref Document

33 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Filgrastim L03Aa02 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8791885

EMD:Ref Document

Bid Value: Ref Document

3 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Golimumab L04Ab06 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8791055

EMD:Ref Document

Bid Value: Ref Document

3 Days Left

Purchase And Maintenance Of Light And Utility Vehicles

Deadline: 10 Oct 2026

France

Ref. No.: 8790822

EMD:Ref Document

Bid Value: Ref Document

43 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Erythropoietin B03Xa01 Within The Framework Of A So Called Open House Model

Deadline: 31 Aug 2026

Germany

Ref. No.: 8789001

EMD:Ref Document

Bid Value: Ref Document

3 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Olanzapine N05Ah03 Without Solid Oral Dosage Forms As Part Of A So Called Open Hou

Deadline: 31 Aug 2026

Germany

Ref. No.: 8788988

EMD:Ref Document

Bid Value: Ref Document

3 Days Left

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Filter Your Search

FREE Trial plan for all new users!